Skip to content

The End of Alzheimer's: The First Program to Prevent and Reverse Cognitive
Stock Photo: Cover May Be Different

The End of Alzheimer's: The First Program to Prevent and Reverse Cognitive Decline Hardcover - 2017 - 1st Edition

by Bredesen, Dale

  • Used
  • Good
  • Hardcover

Description

Hardcover. Good.
Used - Good
NZ$8.32
NZ$5.00 Shipping to USA
Standard delivery: 2 to 8 days
More Shipping Options
Ships from Shred-Ex, LLC (Vermont, United States)

Details

  • Title The End of Alzheimer's: The First Program to Prevent and Reverse Cognitive Decline
  • Author Bredesen, Dale
  • Binding Hardcover
  • Edition number 1st
  • Edition 1
  • Condition Used - Good
  • Pages 320
  • Volumes 1
  • Language ENG
  • Publisher Avery Publishing Group
  • Date 2017-08-22
  • Illustrated Yes
  • Features Bibliography, Illustrated, Index
  • Bookseller's Inventory # TY-T23Z-WX1S
  • ISBN 9780735216204 / 0735216207
  • Weight 1.05 lbs (0.48 kg)
  • Dimensions 9.1 x 6.2 x 1.3 in (23.11 x 15.75 x 3.30 cm)
  • Themes
    • Topical: Health & Fitness
  • Library of Congress subjects Alzheimer's disease - Prevention, Alzheimer's disease - Treatment
  • Library of Congress Catalog Number 2017029515
  • Dewey Decimal Code 616.831

About Shred-Ex, LLC Vermont, United States

Biblio member since 2022
Seller rating: This seller has earned a 1 of 5 Stars rating from Biblio customers.

Shredding, Destruction company.

Terms of Sale: 30 day return guarantee, with full refund including original shipping costs for up to 30 days after delivery if an item arrives misdescribed or damaged.

Browse books from Shred-Ex, LLC

About the author

Dale Bredesen, M.D., is internationally recognized as an expert in the mechanisms of neurodegenerative diseases such as Alzheimer's disease. He graduated from Caltech, then earned his M.D. from Duke University Medical Center in Durham, North Carolina. He served as chief resident in neurology at the University of California, San Francisco (UCSF) before joining Nobel laureate Stanley Prusiner's laboratory at UCSF as an NIH postdoctoral fellow. He held faculty positions at UCSF, UCLA, and the University of California, San Diego. Dr. Bredesen directed the Program on Aging at the Burnham Institute before coming to the Buck Institute in 1998 as its founding president and CEO. He is the chief medical officer of MPI Cognition.